Clinical Performance of the 1st American Academy of Orthopaedic Surgeons Clinical Guideline on Prevention of Symptomatic Pulmonary Embolism after Total Knee Arthroplasty in Korean Patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 나영곤 | - |
dc.contributor.author | Rui Fang | - |
dc.contributor.author | 김연호 | - |
dc.contributor.author | 조관재 | - |
dc.contributor.author | 김태균 | - |
dc.date.accessioned | 2021-09-23T00:41:21Z | - |
dc.date.available | 2021-09-23T00:41:21Z | - |
dc.date.created | 2021-09-23 | - |
dc.date.issued | 2015-12 | - |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/82193 | - |
dc.description.abstract | We sought to document the clinical performance of the 1st American Academy of Orthopaedic Surgeons (AAOS) guideline on the prevention of symptomatic pulmonary embolism (PE) after total knee arthroplasty (TKA) in Korean patients, in terms of the proportions of the each risk-stratified group, efficacy and safety. Consecutive 328 patients underwent TKA were preoperatively assessed for the risks of PE and bleeding and categorized into 4 groups: 1) standard risk, 2) high risk for PE, 3) high risk for bleeding, and 4) high risks both for PE and bleeding. One of three options was administered according to the groups (aspirin in group 1 or 4; enoxaparin and following aspirin in group 2; antithrombotic stocking in group 3). Incidences of symptomatic deep vein thrombosis (DVT) and PE, and major or minor bleeding complications were evaluated. Majority of the patients (86%) were assessed to be with standard risks both for PE and bleeding. No patient experienced symptomatic DVT or PE and major bleeding. Eleven percent of the patients discontinued chemoprophylaxis because of bleeding-related wound complication. In conclusion, the 1st AAOS guideline functions successfully in Korean patients undergoing TKA in terms of prevention of symptomatic DVT and PE while avoiding major bleeding complications. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 대한의학회 | - |
dc.relation.isPartOf | Journal of Korean Medical Science | - |
dc.title | Clinical Performance of the 1st American Academy of Orthopaedic Surgeons Clinical Guideline on Prevention of Symptomatic Pulmonary Embolism after Total Knee Arthroplasty in Korean Patients | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000368136400022 | - |
dc.identifier.doi | 10.3346/jkms.2015.30.12.1865 | - |
dc.identifier.bibliographicCitation | Journal of Korean Medical Science, v.30, no.12, pp.1865 - 1873 | - |
dc.identifier.kciid | ART002055487 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-84951764360 | - |
dc.citation.endPage | 1873 | - |
dc.citation.startPage | 1865 | - |
dc.citation.title | Journal of Korean Medical Science | - |
dc.citation.volume | 30 | - |
dc.citation.number | 12 | - |
dc.contributor.affiliatedAuthor | 나영곤 | - |
dc.subject.keywordAuthor | Arthroplasty | - |
dc.subject.keywordAuthor | Replacement | - |
dc.subject.keywordAuthor | Knee | - |
dc.subject.keywordAuthor | Venous Thromboembolism | - |
dc.subject.keywordAuthor | Pulmonary Embolism | - |
dc.subject.keywordAuthor | Venous Thrombosis | - |
dc.subject.keywordAuthor | Hemorrhage | - |
dc.subject.keywordAuthor | Chemoprevention | - |
dc.subject.keywordAuthor | Aspirin | - |
dc.subject.keywordAuthor | Enoxaparin | - |
dc.subject.keywordAuthor | AAOS Guideline | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.